MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0006818
Pellsys Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.54 Cr
▼ 3% YoY
Net profit · FY 2025
₹19.42 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹1.44 Cr
EBITDA margin 4.9%
Authorised capital
₹2.32 Cr
Registered with MCA
Paid-up capital
₹2.32 Cr
Issued & subscribed
Open charges
₹2.5 Cr
Satisfied ₹3 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
40
Provident fund records
About Pellsys Pharma Private Limited
Data last updated:
Pellsys Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 December 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2008PTC062293. Its GSTIN is 36AAECP8978R1Z6 (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2.32 Cr and a paid-up capital of ₹2.32 Cr. It is led by directors including Srinulakshmi Perumallu Chaladi (Managing Director) and Cherupalli Ganesh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 73 Road No 03 I.D.A. Cherlapally Phase – 1, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.54 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹19.42 Lakh (net margin 0.7%) and EBITDA of ₹1.44 Cr (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 8% over five years.
The company has about 40 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pellsys Pharma. As per MCA filings, the company has open charges of ₹2.5 Cr and satisfied charges of ₹3 Cr on record.
Pellsys Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0006818). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pellsyspharma.com.
Company details
CIN U24233TG2008PTC062293
Registration Number 062293
Incorporation Date 19 December 2008
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0006818
CIN history
Pellsys Pharma has one previous CIN (Corporate Identification Number): U24233AP2008PTC062293. The current CIN is U24233TG2008PTC062293, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2008PTC062293 | Current |
| U24233AP2008PTC062293 | Previous |
Key People
Srinulakshmi Perumallu Chaladi Managing Director Cherupalli Ganesh Whole-Time Director Ramesh Babu Sarvisetty Whole-Time Director Recognitions & Rankings of Pellsys Pharma
Contact details
Pellsys Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is pellsyspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 73 Road No 03 I.D.A. Cherlapally Phase – 1, Hyderabad, Telangana, India – 500051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pellsys Pharma Private Limited, buy the company report.
Comprehensive company report
Pellsys Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Pellsys Pharma operates one associated brand: Pellsys Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies pellet-based pharmaceutical products. | pellsyspharma.com |
Business activity
The main business activity of Pellsys Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pellsys Pharma Private Limited, buy the company report.
Financials of Pellsys Pharma Private Limited
FY 2025 filings availablePellsys Pharma Private Limited reported revenue of ₹29.54 Cr (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹29.54 Cr ▼ 3%
Net profit · FY 2025
₹19.42 Lakh margin 0.7%
EBITDA · FY 2025
₹1.44 Cr margin 4.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 6%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 12%
5 years · compounded
▼ 12%
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.44 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.42 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pellsys Pharma Private Limited, buy the company report.
Board of directors of Pellsys Pharma Private Limited
Pellsys Pharma has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venugopal Setty Sarvisetty Also directs: Housz Buildtech LLP, Vital Therapeutics Private Limited, Vital Therapeutics and Formulations Private Limited and 2 more | Director | 09 Jul 2013 | 13 Years 4 Months | Current |
| Cherupalli Ganesh | Whole-Time Director | 19 Dec 2008 | 17 Years 10 Months | Current |
| Ramesh Babu Sarvisetty | Whole-Time Director | 09 Jul 2013 | 13 Years 4 Months | Current |
| Srinulakshmi Perumallu Chaladi | Managing Director | 19 Dec 2008 | 17 Years 10 Months | Current |
Peer comparison
Pellsys Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kedar Janani Chemplast Private Limited | ₹29.84 Cr (FY 2025) | 26.0% | Mumbai, Maharashtra, India | |||
| Pellsys Pharma Private Limitedthis company | ₹29.54 Cr (FY 2025) | ₹19.42 Lakh | 0.7% | -3.0% | 40 | Hyderabad, Telangana, India |
| Medion Biotech Private Limited | ₹29.5 Cr (FY 2025) | 1.0% | Delhi, India | |||
| Rapross Pharmaceuticals Private Limited | ₹29.39 Cr (FY 2023) | 3.0% | Delhi, India |
To see the full peer comparison of Pellsys Pharma Private Limited, buy the company report.
Auditor
Pellsys Pharma Private Limited is audited by T BADARINATH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T BADARINATH & ASSOCIATES | FY 2023 | 000301S |
Shareholding
The shareholding of Pellsys Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pellsys Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.5 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Aug 2014 | 10520082 | Hdfc Bank Limited | ₹2.5 Cr | Open | |
| 07 Sep 2009 | 10179461 | State Bank of Patiala | ₹3 Cr | Satisfied |
To see the full charge records of Pellsys Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Pellsys Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Pellsys Pharma Private Limited has 10 MSME Form 1 returns on record between 2018 and 2023, listing 135 overdue payments to 38 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 38)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Accurate Engineers | |||
| Pure Chem Pvt Ltd | |||
| Vikram Thermo (India) Limited | |||
| Minerva Biogenix Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Pellsys Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Pellsys Pharma Private Limited has a workforce of 40 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
40
Active EPFO establishments
1
Employee growth
25%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 40 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Pellsys Pharma Private Limited, buy the company report.
GST
Pellsys Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECP8978R1Z6 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pellsys Pharma Private Limited, buy the company report.
Recent activity
Pellsys Pharma Private Limited has 10 board changes on record since 2008: 4 appointments and 6 cessations. The latest: Kishore Kumar Gattam ceased to be Director on 09 Jul 2013.
AGM
Pellsys Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pellsys Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited of Rs. 2.50 Cr registered on 26 Aug 2014 with Charge ID 10520082 was modified on 22 Feb 2022.
Charges
A charge registered on 07 Sep 2009 via Charge ID 10179461 with State Bank Of Patiala was fully satisfied on 27 Oct 2014.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.50 Cr with Charge ID 10520082 was registered on 26 Aug 2014.
Ceased
Kishore Kumar Gattam ceased to be Director.
Appointed
Ramesh Babu Sarvisetty was appointed as Whole-Time Director.
Ceased
Ramesh Babu Sarvisetty ceased to be Additional Director.
Ceased
Venkateswara Rao Chitturi ceased to be Director.
Appointed
Venugopal Setty Sarvisetty was appointed as Director.
Ceased
Venugopal Setty Sarvisetty ceased to be Additional Director.
Charges
A charge with State Bank Of Patiala of Rs. 3.00 Cr registered on 07 Sep 2009 with Charge ID 10179461 was modified on 30 Jan 2012.
6 earlier events are in the company report.
Frequently asked questions
Pellsys Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 December 2008 (18+ years old) and is registered under CIN U24233TG2008PTC062293.
Pellsys Pharma has 4 current directors:
- Srinulakshmi Perumallu Chaladi - Managing Director
- Cherupalli Ganesh - Whole-Time Director
- Ramesh Babu Sarvisetty - Whole-Time Director
- Venugopal Setty Sarvisetty - Director
The latest financial statements of Pellsys Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Pellsys Pharma is 36AAECP8978R1Z6, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Pellsys Pharma is U24233TG2008PTC062293. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pellsys Pharma was incorporated on 19 December 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Pellsys Pharma by revenue are Kedar Janani Chemplast Private Limited, Medion Biotech Private Limited, Rapross Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kishore Kumar Gattam ceased to be Director on 09 Jul 2013. Ramesh Babu Sarvisetty was appointed as Whole-Time Director on 09 Jul 2013. Ramesh Babu Sarvisetty ceased to be Additional Director on 09 Jul 2013. Pellsys Pharma has 10 board changes on record in total.
Yes, Pellsys Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0006818).
Pellsys Pharma has 10 MSME Form 1 returns on record between 2018 and 2023, listing 135 overdue payments to 38 micro and small suppliers. The latest return was filed on 27 Aug 2023.
Pellsys Pharma can be reached through the website pellsyspharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Pellsys Pharma is at Plot No. 73 Road No 03 I.D.A. Cherlapally Phase – 1, Hyderabad, Telangana, India – 500051.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages